Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPR158 antisense RNA 1 (GPR158-AS1) is a long non-coding RNA gene transcribed from the region antisense to the GPR158 gene. It does not encode a protein and is classified within the lncRNA family. Current literature links GPR158-AS1 mainly to gene regulation at the RNA level, but its explicit functions and mechanisms have not been well characterized. It has been noted in gene-disease association studies, primarily with retinitis pigmentosa, but its involvement in pathology is unclear. No drugs or therapeutic interventions targeting GPR158-AS1 are described in available sources, and it is not recognized as a conventional therapeutic target such as a receptor, enzyme, or transporter[3][6]. If you intended information on the related protein-coding gene (GPR158, a "G protein-coupled receptor"), please clarify, as this would refer to an entirely different type of target with substantial pharmacological research and distinct biological roles[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GPR158 antisense RNA 1 (GPR158-AS1).